Cart
sales@molnova.com
CPI-203
CAS No. 202591-23-9
CPI-203( —— )
Catalog No. M13155 CAS No. 202591-23-9
CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 68 | In Stock |
|
| 50MG | 124 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI-203
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
-
DescriptionCPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorBRD4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202591-23-9
-
Formula Weight399.9
-
Molecular FormulaC19H18ClN5OS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 200 mM
-
SMILESCC1=C(C)C2=C(S1)N1C(C)=NN=C1C(CC(N)=O)N=C2C1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Devaiah BN, et al. Proc natl Acad Sci U S A. 2012, 109(18), 6927-6932.
molnova catalog
related products
-
BY27
BY27, a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4, and BRDT, and suppresses tumor growth.
-
GSK620
GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.
-
RVX-208
RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
